SEARCH RESULTS

5409 RESULTS

Sort By:

Traffic Control—Curb Endocytosis to Curb AD Pathogenesis?

RESEARCH NEWS 2011-10-28 Research News One study views Aβ production as a normal part of synaptic plasticity, while another starts with the premise that Aβ buildup in neurons is a bad thing. Yet from these divergent starting points, both arrive at a similar conclusion—the ...

DC: Where Does TDP-43’s Toxic End Really Come From?

CONFERENCE COVERAGE 2011-11-25 Conference Coverage Clearly, the C-terminal of TDP-43 has something to do with amyotrophic lateral sclerosis (ALS). The toxic fragments appear as aggregating, 25- and 35-kiloDalton (kDa) species that supposedly result from cleavage by caspase 3 or another ...

TDP-43 Hangs Out With NF-κB, Puts Innate Immunity Into Hyperdrive

RESEARCH NEWS 2011-12-02 Research News TAR DNA binding protein 43, the RNA-binding protein linked to amyotrophic lateral sclerosis, is in the middle of an abnormal innate immune response that compromises the spinal cord of people with the disease, according to a paper published ...

DC: What’s That New Stuff in and Around Nuclei of AD Cells?

CONFERENCE COVERAGE 2011-12-09 Conference Coverage At this year’s annual meeting of the Society for Neuroscience, the number of mini- and nano-symposia dedicated to the molecular stalwarts of Alzheimer’s disease, Aβ and tau, was strikingly down. The trend may reflect both the field’s ...

SOS: Motor Neurons Send Angiogenin Cry for Help to Astroglia

RESEARCH NEWS 2012-04-16 Research News Floundering motor neurons rely on a support network for help, and they send out a distress call to astroglia in the form of angiogenin, report the authors of a paper in the April 11 Journal of Neuroscience. Angiogenin, a candidate gene for ...

Keystone: TBI—Learning From Markers, Models, and Diseases

CONFERENCE COVERAGE 2012-05-09 Conference Coverage Alzforum thanks Sam Gandy, Soong Ho Kim, and Effie Mitsis at Mount Sinai School of Medicine for preparing this meeting summary, edited by Tom Fagan. Injury to the brain, even what might be considered mild, can have devastating ...

Boost APP Ubiquitination, Wnt Signaling to Stave Off AD?

RESEARCH NEWS 2012-03-09 Research News The prevailing theory that Aβ peptides are a major culprit in Alzheimer’s disease offers no shortage of possible therapeutic approaches—two of which make the pages of this week’s Journal of Neuroscience. Patricia Salinas and colleagues at ...

San Diego: Tau Oligomer Antibodies Relieve Motor Deficits in Mice

CONFERENCE COVERAGE 2010-11-25 Conference Coverage Mirroring a trend in amyloid-β research, work on the tau protein seems to be moving from tangles toward that infamous “O” word—oligomers. At this year’s annual meeting of the Society for Neuroscience (SfN), held 13-17 November in San ...

San Diego: Pilin’ on the Pyro, Aβ Going Rogue

CONFERENCE COVERAGE 2010-11-29 Conference Coverage What causes Aβ to go rogue in Alzheimer’s disease? Some researchers believe that a modified, pyroglutamate form of Aβ is to blame. Pyroglutamate Aβ, first discovered almost 20 years ago, heated up as a research topic in recent years, ...

San Diego: Aβ Oligomers Seen, With ApoE, at Synapses of Human Brain

CONFERENCE COVERAGE 2010-12-06 Conference Coverage Apolipoprotein E is the strongest genetic risk factor for late-onset Alzheimer’s disease, accounting for more than 95 percent of cases. But despite decades of research, it is still not clear how it ties in with AD etiology. At the ...

San Diego: The Curious Case of ApoE, Cholesterol, and Cognition

CONFERENCE COVERAGE 2010-12-08 Conference Coverage Cholesterol not only clogs up arteries and leads to heart disease, but it can be bad for your brain as well. Evidence for cholesterol’s role in Alzheimer’s disease has been growing in recent years, and many cardiovascular risk factors ...

Tau Modification—Move Over Phosphate, Make Room for Acetylation

RESEARCH NEWS 2011-03-25 Research News Before forming neurofibrillary tangles, tau may pick up a few acetyl groups along with the slew of phosphates it brings to the pathological inclusions in tauopathies such as Alzheimer’s disease and frontotemporal lobar dementia (FTLD). ...

Taos: Not the Usual Suspects: PARIS et al. Mark Progress in PD

CONFERENCE COVERAGE 2011-04-28 Conference Coverage In the movie Casablanca, protagonists Rick and Ilsa would always have Paris. Parkinson’s disease researchers always will as well, if a different one. Parkin interacting substrate (PARIS) was not born of the movie screen, but of a ...

San Francisco: Gladstone Institute Hosts Tau Powwow

CONFERENCE COVERAGE 2011-05-12 Conference Coverage Never mind that it featured 29 of the world’s top tau experts reporting the latest on their favorite protein. The recent symposium at the Gladstone Institute of Neurological Disease (GIND), San Francisco, ran less like a formal meeting ...

San Francisco: Tau—Time to Shine as Therapeutic Target?

CONFERENCE COVERAGE 2011-05-17 Conference Coverage At the “Tau and Tauopathies: Pathogenic Mechanisms” workshop held 28-30 March 2011 at the Gladstone Institute of Neurological Disease (GIND) in San Francisco (see Part 1), speakers voiced a sense of welcome relief, perhaps akin to ...

Current Filters

  • TYPE: News x

Remove all filters

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE
TYPE OF NEWS
DISEASE
TOPIC
BIOMOLECULE